Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H23NO |
Molecular Weight | 293.4027 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(C1CN2CCC1CC2)(C3=CC=CC=C3)C4=CC=CC=C4
InChI
InChIKey=PZMAHNDJABQWGS-UHFFFAOYSA-N
InChI=1S/C20H23NO/c22-20(17-7-3-1-4-8-17,18-9-5-2-6-10-18)19-15-21-13-11-16(19)12-14-21/h1-10,16,19,22H,11-15H2
Molecular Formula | C20H23NO |
Molecular Weight | 293.4027 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Quifenadine is an antihistaminic agent.
Quifenadine both blocks histamine H1-receptors in the peripheral tissues, and activates enzyme diaminoxidase (histaminase), due to this decreasing the histamine concentration in tissues.
It is indicated in cases of pollinosis, acute and chronic urticaria, seasonal rhinitis (hay fever), allergic rhinitis, allergic conjunctivitis, angioneurotic Quinqe’s edema, dermatosis (eczema, neurodermatitis, pruritus etc.), allergic reactions caused by food or medicines. Quifanidine exhibits antiarrhythmic activity in children with frequent premature beats, without significant QT prolongation, or sinus node depression.
Approval Year
Sample Use Guides
For adults: single dose is 25-50 mg 2-4 times a day. Maximum daily dose is 200 mg.
For children older than 12 years - 25 mg 2-3 times a day.
The duration of the course of treatment is 10-20 days. If it is necessary, the course of treatment may be repeated.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:19:08 GMT 2023
by
admin
on
Fri Dec 15 16:19:08 GMT 2023
|
Record UNII |
W9A18RJ49B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
||
|
WHO-VATC |
QR06AX31
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
||
|
WHO-ATC |
R06AX31
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C81147
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY | |||
|
SUB10193MIG
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY | |||
|
DB13713
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY | |||
|
10447-39-9
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY | |||
|
4748
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY | |||
|
100000081083
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY | |||
|
CHEMBL1187694
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY | |||
|
65600
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY | |||
|
4714
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY | |||
|
DTXSID6046187
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY | |||
|
C014742
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY | |||
|
W9A18RJ49B
Created by
admin on Fri Dec 15 16:19:08 GMT 2023 , Edited by admin on Fri Dec 15 16:19:08 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |